LH LABCORP HOLDINGS INC.

NYSE labcorp.com


$ 275.75 $ -3.83 (-1.37 %)    

Monday, 27-Oct-2025 17:02:30 EDT
QQQ $ 628.88 $ 10.99 (1.78 %)
DIA $ 475.80 $ 3.14 (0.66 %)
SPY $ 685.51 $ 7.99 (1.18 %)
TLT $ 91.88 $ 0.31 (0.34 %)
GLD $ 367.78 $ -10.51 (-2.78 %)
$ 275.66
$ 277.83
$ 275.90 x 2
$ 283.50 x 150
$ 274.26 - $ 280.36
$ 208.23 - $ 293.72
1,300,827
na
24.4B
$ 0.67
$ 31.96
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2025 06-30-2025 10-Q
2 04-29-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 10-29-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 04-30-2024 03-31-2024 10-Q
7 02-26-2024 12-31-2023 10-K
8 10-30-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-01-2022 06-30-2022 10-Q
14 04-29-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 02-28-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 10-30-2018 09-30-2018 10-Q
29 07-27-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 04-28-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 10-28-2016 09-30-2016 10-Q
37 07-29-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-labcorp-hldgs-raises-price-target-to-325

UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $305 to $325.

 mizuho-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-320

Mizuho analyst Ann Hynes maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $285 to $320.

 evercore-isi-group-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-305

Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price targe...

 labcorp-teams-up-with-roche-to-bring-digital-pathology-scanners-to-us-labs-adopts-new-digital-imaging-tech-to-improve-cancer-and-disease-diagnoses

Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Ro...

 labcorp-announced-the-availability-of-lumipulse-ptau-217beta-amyloid-42-ratio-first-blood-based-in-vitro-diagnostic-test-cleared-by-fda-for-diagnosis-of-alzheimers-disease

The test offers results that are comparable to existing methods that support a diagnosis of Alzheimer's disease – cerebrosp...

 labcorp-secures-ivdr-ce-marking-for-first-of-its-kind-in-vitro-diagnostic-test-for-solid-tumors-in-the-eu

First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for pa...

 truist-securities-maintains-buy-on-labcorp-hldgs-raises-price-target-to-310

Truist Securities analyst David Macdonald maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $290...

 ubs-maintains-buy-on-labcorp-hldgs-raises-price-target-to-305

UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $282 to $305.

 evercore-isi-group-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-300

Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION